The Bill and Melinda Gates Foundation is launching a campaign to highlight the U.S. government's efforts to improve global health, according to Associated Press on Thursday.
Best Damn Penny Stocks, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Stock Newsletter
Bill Gates, the co-founder of Microsoft Corp. (NASDAQ: MSFT), and his wife, created the Living Proof Project after feeling that American people did not understand the message about the impact U.S.-supported initiatives were having in the developing world.
"We want to show Americans that their investments in global health are working," Gates said in a statement announcing the campaign.
The project, launching on Thursday, includes an advertising campaign in Washington and a Web site with personal stories from people who have benefited from U.S. programs.
Support for global health programs increased significantly under former President George W. Bush, who created the President's Emergency Plan for AIDS Relief, called PEPFAR.
The five-year, $15 billion plan began in 2003 with the goal of expanding prevention, treatment and support programs in 15 hard-hit countries. PEPFAR is credited with saving an estimated 1.2 million lives.
Last year, Congress passed and Bush signed legislation to triple spending from to $48 billion over five years.
Though the U.S. is the largest single donor to the developing world, the money spent on global health assistance amounts to less than one percent of the nation's budget.
Sign up for the free Best Damn Penny Stocks newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website
About Best Damn Penny Stocks
Best Damn Penny Stocks is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.
Please click here to read the full disclaimer
